See All Slides - tctmd.com

Slides

Presentation TCT 2014

Antiplatelet Effects of Clopidogrel and Aspirin During 6 Months of Follow-up After Stent Implantation: An ADAPT-DES Substudy

Presenter: Dietmar Trenk

September 16, 2014

Presentation TCT 2014

Cost Comparisons of Invasive and Non-Invasive Diagnostic Evaluations for Patients with Suspected In-Stent Restenosis Following Implant of Metallic Stents and Bioresorbable___

Presenter: James Min

September 16, 2014

Presentation TCT 2014

N-terminal Pro-B-type Natriuretic Peptide Ratio Predicts Mortality After Transcatheter Aortic Valve Replacement

Presenter: Ronald Binder

September 16, 2014

Presentation TCT 2014

Bleeding and Stroke Risk Assessment in Atrial Fibrillation: Choosing between Warfarin, NOACS, Antiplatelets, or Nothing?

Presenter: Matthew J. Price, Michael D. Ezekowitz

September 15, 2014

Presentation TCT 2014

Cobalt-Chromium Sirolimus-Eluting Platforms IV: Firehawk

Presenter: Alexandre Abizaid, Pieter C. Smits, Robert J. Gil, Bo Xu

September 15, 2014

Presentation TCT 2014

Are There Meaningful Differences in Vascular Responses Between the Different Classes of Metallic Stent Technologies?

Presenter: Robert A. Byrne, Didier Carrié, Giuseppe De Luca, Francesco Prati

September 15, 2014

Presentation TCT 2014

Techniques, Results, and Lessons from Surgical LAA Closure

Presenter: Josep Rodés-Cabau, Brian K. Whisenant, David Hildick-Smith, Subhasis Chatterjee

September 15, 2014

Presentation TCT 2014

The REG1 Anticoagulation System: Factor IX Inhibitor Using RNA Aptamer Technology

Presenter: E. Magnus Ohman, Freek W.A. Verheugt, C. Michael Gibson, A. Michael Lincoff

September 15, 2014

Presentation TCT 2014

Case #1: True Bifurcation: Treat with a Dedicated Bifurcation Stent or Two BRS?

Presenter: Chris Kwok Yiu Wong, Alan C. Yeung, Robaayah Zambahari, Kam-Tim Chan

September 15, 2014

Presentation TCT 2014

Post-TAVR Valve Assessment: Can We Improve Our Accuracy?

Presenter: Sherif F. Nagueh, Neil J. Weissman, Philippe Pibarot

September 15, 2014

Advertisement

Slides

Antiplatelet Effects of Clopidogrel and Aspirin During 6 Months of Follow-up After Stent Implantation: An ADAPT-DES Substudy

Cost Comparisons of Invasive and Non-Invasive Diagnostic Evaluations for Patients with Suspected In-Stent Restenosis Following Implant of Metallic Stents and Bioresorbable___

N-terminal Pro-B-type Natriuretic Peptide Ratio Predicts Mortality After Transcatheter Aortic Valve Replacement

Bleeding and Stroke Risk Assessment in Atrial Fibrillation: Choosing between Warfarin, NOACS, Antiplatelets, or Nothing?

Cobalt-Chromium Sirolimus-Eluting Platforms IV: Firehawk

Are There Meaningful Differences in Vascular Responses Between the Different Classes of Metallic Stent Technologies?

Techniques, Results, and Lessons from Surgical LAA Closure

The REG1 Anticoagulation System: Factor IX Inhibitor Using RNA Aptamer Technology

Case #1: True Bifurcation: Treat with a Dedicated Bifurcation Stent or Two BRS?

Post-TAVR Valve Assessment: Can We Improve Our Accuracy?

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content